Concise review: Human pluripotent stem cells in the treatment of spinal cord injury

Stem Cells

Volumn 30, Issue 9, 2012, Pages 1787-1792

  Lukovic, Dunja ^a   Manzano, Victoria Moreno ^b   Stojkovic, Miodrag ^c,d   Bhattacharya, Shom Shanker ^a   Erceg, Slaven ^a,e  

^a CABIMER Andalusian Center for Molecular Biology and Regenerative Medicine CSIC University of Seville UPO   (Spain)

^b CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

^c Spebo Medical ^*  (Serbia)

^d UNIVERSITY OF KRAGUJEVAC   (Serbia)

^e Medical Genome Project   (Spain)

Author keywords

Embryonic stem cells; Induced pluripotent stem cells; Spinal cord injury; Stem cell transplantation; Tissue regeneration

Indexed keywords

OLIGODENDROCYTE TRANSCRIPTION FACTOR 2;

CELL DEATH; CELL LOSS; CLINICAL PRACTICE; EMBRYONIC STEM CELL; HUMAN; HUMAN EMBRYONIC STEM CELL; NERVE CELL; NONHUMAN; OLIGODENDROGLIA; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; SHORT SURVEY; SPINAL CORD INJURY; SPINAL CORD LESION; STEM CELL TRANSPLANTATION;

ANIMALS; EMBRYONIC STEM CELLS; HUMANS; PLURIPOTENT STEM CELLS; SPINAL CORD INJURIES;

EID: 84865312600     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1159     Document Type: Short Survey

References (75)

1. Ronaghi M, Erceg S, Moreno-Manzano V et al. Challenges of stem cell therapy for spinal cord injury: Human embryonic stem cells, endogenous neural stem cells, or induced pluripotent stem cells? Stem Cells 2010;28:93-99.
2. Hulsebosch CE. Recent advances in pathophysiology and treatment of spinal cord injury. Adv Physiol Educ 2002;26:238-255.
3. McTigue DM, Tani M, Krivacic K et al. Selective chemokine mRNA accumulation in the rat spinal cord after contusion injury. J Neurosci Res 1998;53:368-376.
4. Grossman SD, Rosenberg LJ, Wrathall JR. Temporal-spatial pattern of acute neuronal and glial loss after spinal cord contusion. Exp Neurol 2001;168:273-282.
5. Kakulas BA. The applied neuropathology of human spinal cord injury. Spinal Cord 1999;37:79-88.
6. Beattie MS, Li Q, Bresnahan JC. Cell death and plasticity after experimental spinal cord injury. Prog Brain Res 2000;128:9-21.
7. Rowland JW, Hawryluk GW, Kwon B et al. Current status of acute spinal cord injury pathophysiology and emerging therapies: Promise on the horizon. Neurosurg Focus 2008;25:E2.
8. Hagino S, Iseki K, Mori T et al. Slit and glypican-1 mRNAs are coexpressed in the reactive astrocytes of the injured adult brain. Glia 2003;42:130-138.
9. Bundesen LQ, Scheel TA, Bregman BS et al. Ephrin-B2 and EphB2 regulation of astrocyte-meningeal fibroblast interactions in response to spinal cord lesions in adult rats. J Neurosci 2003;23:7789-7800.
10. Taoka Y, Okajima K. Spinal cord injury in the rat. Prog Neurobiol 1998;56:341-358.
11. Erceg S, Ronaghi M, Oria M et al. Transplanted oligodendrocytes and motoneuron progenitors generated from human embryonic stem cells promote locomotor recovery after spinal cord transection. Stem Cells 2010;28:1541-1549.
12. Erceg S, Lainez S, Ronaghi M et al. Differentiation of human embryonic stem cells to regional specific neural precursors in chemically defined medium conditions. PLoS One 2008;3:e2122.
13. Keirstead HS, Nistor G, Bernal G et al. Human embryonic stem cellderived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci 2005;25:4694-4705.
14. Lee H, Shamy GA, Elkabetz Y et al. Directed differentiation and transplantation of human embryonic stem cell-derived motoneurons. Stem Cells 2007;25:1931-1939.
15. Erceg S, Ronaghi M, Stojkovic M. Human embryonic stem cell differentiation toward regional specific neural precursors. Stem Cells 2009;27:78-87.
16. Nistor GI, Totoiu MO, Haque N et al. Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia 2005;49:385-396.
17. Sharp J, Hatch M, Nistor G et al. Derivation of oligodendrocyte progenitor cells from human embryonic stem cells. Methods Mol Biol 2011;767:399-409.
18. Sharp J, Frame J, Siegenthaler M et al. Human embryonic stem cellderived oligodendrocyte progenitor cell transplants improve recovery after cervical spinal cord injury. Stem Cells 2010;28:152-163.
19. Moreno-Manzano V, Rodriguez-Jimenez FJ, Garcia-Rosello M et al. Activated spinal cord ependymal stem cells rescue neurological function. Stem Cells 2009;27:733-743.
20. Watson RA, Yeung TM. What is the potential of oligodendrocyte progenitor cells to successfully treat human spinal cord injury? BMC Neurol 2011;11:113.
21. Kerr CL, Letzen BS, Hill CM et al. Efficient differentiation of human embryonic stem cells into oligodendrocyte progenitors for application in a rat contusion model of spinal cord injury. Int J Neurosci 2010;120:305-313.
22. Cao Q, He Q, Wang Y et al. Transplantation of ciliary neurotrophic factor-expressing adult oligodendrocyte precursor cells promotes remyelination and functional recovery after spinal cord injury. J Neurosci 2010;30:2989-3001.
23. Lu QR, Yuk D, Alberta JA et al. Sonic hedgehog-regulated oligodendrocyte lineage genes encoding bHLH proteins in the mammalian central nervous system. Neuron 2000;25:317-329.
24. Zhou Q, Wang S, Anderson DJ. Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors. Neuron 2000;25:331-343.
25. Hu BY, Du ZW, Li XJ et al. Human oligodendrocytes from embryonic stem cells: Conserved SHH signaling networks and divergent FGF effects. Development 2009;136:1443-1452.
26. Lu QR, Sun T, Zhu Z et al. Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. Cell 2002;109:75-86.
27. Zhou Q, Anderson DJ. The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification. Cell 2002;109:61-73.
28. Brustle O, Maskos U, McKay RD. Host-guided migration allows targeted introduction of neurons into the embryonic brain. Neuron 1995;15:1275-1285.
29. Shihabuddin LS, Horner PJ, Ray J et al. Adult spinal cord stem cells generate neurons after transplantation in the adult dentate gyrus. J Neurosci 2000;20:8727-8735.
30. Pluchino S, Zanotti L, Rossi B et al. Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 2005;436:266-271.
31. Zhang SC. Neural subtype specification from embryonic stem cells. Brain Pathol 2006;16:132-142.
32. Courtine G, Bunge MB, Fawcett JW et al. Can experiments in nonhuman primates expedite the translation of treatments for spinal cord injury in humans? Nat Med 2007;13:561-566.
33. Kwon BK, Hillyer J, Tetzlaff W. Translational research in spinal cord injury: A survey of opinion from the SCI community. J Neurotrauma 2010;27:21-33.
34. Bretzner F, Gilbert F, Baylis F et al. Target populations for first-inhuman embryonic stem cell research in spinal cord injury. Cell Stem Cell 2011;8:468-475.
35. Wirth E, 3rd, Lebkowski JS, Lebacqz K. Response to Frederic Bretzner et al. "Target populations for first-in-human embryonic stem cell research in spinal cord injury". Cell Stem Cell 2011;8:476-478.
36. Solbakk JH, Zoloth L. The tragedy of translation: The case of "first use" in human embryonic stem cell research. Cell Stem Cell 2011;8:479-481.
37. Schwartz SD, Hubschman JP, Heilwell G et al. Embryonic stem cell trials for macular degeneration: A preliminary report. Lancet 2010;379:713-720.
38. Jessell TM. Neuronal specification in the spinal cord: Inductive signals and transcriptional codes. Nat Rev Genet 2000;1:20-29.
39. Wichterle H, Lieberam I, Porter JA et al. Directed differentiation of embryonic stem cells into motor neurons. Cell 2002;110:385-397.
40. Zhang Y, Wang J, Chen G et al. Inhibition of Sirt1 promotes neural progenitors toward motoneuron differentiation from human embryonic stem cells. Biochem Biophys Res commun 2011;404:610-614.
41. Nizzardo M, Simone C, Falcone M et al. Human motor neuron generation from embryonic stem cells and induced pluripotent stem cells. Cell Mol Life Sci 2010;67:3837-3847.
42. Wada T, Honda M, Minami I et al. Highly efficient differentiation and enrichment of spinal motor neurons derived from human and monkey embryonic stem cells. PLoS One 2009;4:e6722.
43. Li XJ, Hu BY, Jones SA et al. Directed differentiation of ventral spinal progenitors and motor neurons from human embryonic stem cells by small molecules. Stem Cells (Dayton, Ohio) 2008;26:886-893.
44. Singh Roy N, Nakano T, Xuing L et al. Enhancer-specified GFP-based FACS purification of human spinal motor neurons from embryonic stem cells. Exp Neurol 2005;196:224-234.
45. Shin S, Dalton S, Stice SL. Human motor neuron differentiation from human embryonic stem cells. Stem Cells Dev 2005;14:266-269.
46. Hu BY, Zhang SC. Differentiation of spinal motor neurons from pluripotent human stem cells. Nat Protocls 2009;4:1295-1304.
47. Li XJ, Du ZW, Zarnowska ED et al. Specification of motoneurons from human embryonic stem cells. Nat Biotechnol 2005;23:215-221.
48. Guo SZ, Ren XJ, Wu B et al. Preparation of the acellular scaffold of the spinal cord and the study of biocompatibility. Spinal Cord 2010;48:576-581.
49. Tate CC, Shear DA, Tate MC et al. Laminin and fibronectin scaffolds enhance neural stem cell transplantation into the injured brain. J Tissue Eng Regen Med 2009;3:208-217.
50. Hatami M, Mehrjardi NZ, Kiani S et al. Human embryonic stem cell-derived neural precursor transplants in collagen scaffolds promote recovery in injured rat spinal cord. Cytotherapy 2009;11:618-630.
51. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-872.
52. Raya A, Rodriguez-Piza I, Guenechea G et al. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 2009;460:53-59.
53. Dimos JT, Rodolfa KT, Niakan KK et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008;321:1218-1221.
54. Karumbayaram S, Kelly TK, Paucar AA et al. Human embryonic stem cell-derived motor neurons expressing SOD1 mutants exhibit typical signs of motor neuron degeneration linked to ALS. Dis Model Mech 2009;2:189-195.
55. Karumbayaram S, Novitch BG, Patterson M et al. Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells 2009;27:806-811.
56. Wernig M, Zhao JP, Pruszak J et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci USA 2008;105:5856-5861.
57. Hotta A, Cheung AY, Farra N et al. Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency. Nat Methods 2009;6:370-376.
58. Ebert AD, Yu J, Rose FF, Jr. et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009;457:277-280.
59. Zhang N, An MC, Montoro D et al. Characterization of human Huntington's disease cell model from induced pluripotent stem cells. PLoS Curr 2010;2:RRN1193.
60. Ku S, Soragni E, Campau E et al. Friedreich's ataxia induced pluripotent stem cells model intergenerational GAATTC triplet repeat instability. Cell Stem Cell 2010;7:631-637.
61. Soldner F, Hockemeyer D, Beard C et al. Parkinson's disease patientderived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009;136:964-977.
62. Warren L, Manos PD, Ahfeldt T et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 2010;7:618-630.
63. Zhou H, Wu S, Joo JY et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem cell 2009;4:381-384.
64. Zhao T, Zhang ZN, Rong Z et al. Immunogenicity of induced pluripotent stem cells. Nature 2011;474:212-215.
65. Apostolou E, Hochedlinger K. Stem cells: iPS cells under attack. Nature 2011;474:165-166.
66. Chin MH, Mason MJ, Xie W et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 2009;5:111-123.
67. Kim DS, Lee JS, Leem JW et al. Robust enhancement of neural differentiation from human ES and iPS cells regardless of their innate difference in differentiation propensity. Stem Cell Rev 2010;6:270-281.
68. Ben-David U, Benvenisty N. The tumorigenicity of human embryonic and induced pluripotent stem cells. Nature Rev 2011;11:268-277.
69. Tsuji O, Miura K, Okada Y et al. Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. Proc Natl Acad Sci USA 2010;107:12704-12709.
70. Nori S, Okada Y, Yasuda A et al. Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice. Proc Natl Acad Sci USA 2011;108:16825-16830.
71. Fujimoto Y, Abematsu M, Falk A et al. Treatment of a mouse model of spinal cord injury by transplantation of human iPS cell-derived long-term self-renewing neuroepithelial-like stem cells. Stem Cells 2012;30:1163-1173.
72. Li JY, Christophersen NS, Hall V et al. Critical issues of clinical human embryonic stem cell therapy for brain repair. Trends Neurosci 2008;31:146-153.
73. Amariglio N, Hirshberg A, Scheithauer BW et al. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med 2009;6:e1000029.
74. Vierbuchen T, Ostermeier A, Pang ZP et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010;463:1035-1041.
75. Chambers SM, Studer L. Cell fate plug and play: Direct reprogramming and induced pluripotency. Cell 2011;145:827-830.